LEUKERAN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Leukeran, and when can generic versions of Leukeran launch?
Leukeran is a drug marketed by Waylis Therap and is included in one NDA.
The generic ingredient in LEUKERAN is chlorambucil. There is one drug master file entry for this compound. Two suppliers are listed for this compound. Additional details are available on the chlorambucil profile page.
Summary for LEUKERAN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 124 |
Clinical Trials: | 6 |
Patent Applications: | 4,949 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for LEUKERAN |
What excipients (inactive ingredients) are in LEUKERAN? | LEUKERAN excipients list |
DailyMed Link: | LEUKERAN at DailyMed |
Recent Clinical Trials for LEUKERAN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
TG Therapeutics, Inc. | Phase 3 |
University of Liverpool | Phase 3 |
Chugai Pharma USA | Phase 3 |
Pharmacology for LEUKERAN
Drug Class | Alkylating Drug |
Mechanism of Action | Alkylating Activity |
Anatomical Therapeutic Chemical (ATC) Classes for LEUKERAN
US Patents and Regulatory Information for LEUKERAN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Waylis Therap | LEUKERAN | chlorambucil | TABLET;ORAL | 010669-002 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |